10-K Decoder · All companies

Anavex Life Sciences Corp.

AVXL · FY2025 · Fiscal year ended Sep 30, 2025 · 10-K filed Nov 2025

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$51.4M−$52.9M+2.8%
Net income−$46.4M−$43.0M−7.9%

Latest quarter: Q3 FY2026

Form 10-Q · Three months ended Jun 30, 2026 · filed Aug 28, 2026

$Q3 FY2026Year earlierChange
Revenue$0K$0K
Operating income$6.70M−$14.5M
Net income$7.80M−$13.2M

Q3 FY2026 dashboardQ3 FY2026 infographic

Questions

What was Anavex Life Sciences's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Sep 30, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Nov 2025.
Was Anavex Life Sciences profitable in FY2025?
No: net income was −$46.4M and operating income −$51.4M in FY2025.
What was Anavex Life Sciences's revenue in Q3 FY2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Aug 28, 2026.